Mrs. Jennifer L Rewa, OT Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5831 128th Ave, Fennville, MI 49408 Phone: 269-561-6540 Fax: 269-561-6540 |
News Archive
Can a very common allergy medicine improve survival among patients suffering from the serious skin cancer, malignant melanoma? A new study from Lund University in Sweden indicates that this may be the case.
The Center for Global Health Policy's "Science Speaks" blog includes a summary of a recent Global Fund meeting on HIV financing. "The most dynamic and passionate remarks came from Morolake Odetoyinbo, CEO of the non-governmental organization Positive Action for Treatment Access in Nigeria and a woman living with HIV/AIDS. She argued that African nations were not doing enough to use their resources to care for their own people," according to the post.
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China today reported financial results for the three months ended March 31, 2015.
Beckman Coulter, Inc., the leader in prostate cancer diagnostics, announces Premarket Approval (PMA) from the U.S. Food and Drug Administration (FDA) for the Prostate Health Index (phi), a simple, non-invasive blood test that is 2.5-times more specific in detecting prostate cancer than PSA (prostate-specific antigen) in patients with PSA values in the 4-10 ng/mL range and is proven to reduce the number of prostate biopsies.
St. Jude Children's Research Hospital scientists have used sophisticated pharmacologic modeling and simulation to translate preclinical findings into a successful phase I clinical trial of a chemotherapy agent for treatment of ependymoma. The research marked the first time the approach has been used to calculate drug doses for a clinical trial in pediatric brain tumor patients.
› Verified 4 days ago